Dupixent is available as a solution inside single-dose prefilled pens and syringes, given as a subcutaneous injection. Dupixent is a biologic and belongs to a drug class called interleukin-4 (IL-4 ...
CEO Leonard Schleifer highlighted 10% revenue growth in Q4 2024, attributed to strong performance from Dupixent ... with the launch of a prefilled syringe in mid-2025 and label expansions for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback